Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any cataract in which the cause of the disease is a mutation in the FYCO1 gene.
Features include: Nuclear cataract.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 1 | Nuclear cataract |
FYCO1 encodes FYVE and coiled-coil domain autophagy adaptor 1 (1,478 aa). May mediate microtubule plus end-directed vesicle transport Highest expression in Muscle Skeletal (74.0 TPM) and Artery Tibial (72.6 TPM).
Cataract 18 is associated with mutations in the FYCO1 gene on chromosome 3.
FYCO1 is classified as a druggable target with score 0.0.
Genetic testing for FYCO1 is available. Testing is considered confirmatory for diagnosis.
No clinical trials have been registered for cataract 18.
216 publications have been identified in PubMed for cataract 18. Kisho has analyzed 87 by research type. Research spans Epidemiology / Natural History (46%), Review / Meta-Analysis (17%), and Clinical Trial Publication (17%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 40 | 46% |
Data assembled from 5 of 12 sources · Last updated Sep 18, 2026, 6:57 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Research summaries
15 |
17% |
Clinical study results | 15 | 17% |
Laboratory research | 12 | 14% |
Patient case studies | 3 | 3% |
New treatment approaches | 2 | 2% |
Chen X (2026). [PMID: 42267952](https://pubmed.ncbi.nlm.nih.gov/42267952/). *Retina*. [Gene Therapy / Novel Therapeutics]
Ray A (2026). [PMID: 34283446](https://pubmed.ncbi.nlm.nih.gov/34283446/). *Unknown Journal*. [Epidemiology / Natural History]
McCormick I (2026). [PMID: 41687671](https://pubmed.ncbi.nlm.nih.gov/41687671/). *Lancet Glob Health*. [Epidemiology / Natural History]
Zhang X (2026). [PMID: 41735671](https://pubmed.ncbi.nlm.nih.gov/41735671/). *Arch Osteoporos*. [Basic Science / Preclinical]
Lakhani M (2025). [PMID: 40505686](https://pubmed.ncbi.nlm.nih.gov/40505686/). *Can J Ophthalmol*. [Epidemiology / Natural History]
Tian ZY (2025). [PMID: 39853565](https://pubmed.ncbi.nlm.nih.gov/39853565/). *Int Ophthalmol*. [Review / Meta-Analysis]
Ta H (2025). [PMID: 39806338](https://pubmed.ncbi.nlm.nih.gov/39806338/). *BMC Ophthalmol*. [Review / Meta-Analysis]
Liu YL (2025). [PMID: 40932733](https://pubmed.ncbi.nlm.nih.gov/40932733/). *JAMA Ophthalmol*. [Epidemiology / Natural History]
Qi J (2025). [PMID: 40768632](https://pubmed.ncbi.nlm.nih.gov/40768632/). *Aging Dis*. [Epidemiology / Natural History]
Zhang Y (2025). [PMID: 39672488](https://pubmed.ncbi.nlm.nih.gov/39672488/). *Am J Ophthalmol*. [Epidemiology / Natural History]